Comparison of the Effectiveness of Treadmill-Based Walking and Dual-Task Walking Training in Alzheimer's Disease
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Dec 9, 2024
Trial Information
Current as of October 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective a special type of exercise is for people with Alzheimer's disease. Researchers want to see if combining walking on a treadmill with tasks that challenge the brain—like solving simple puzzles—can help improve both movement and thinking skills more than just walking alone. They believe that this dual-task training could make daily activities easier for individuals facing the challenges of Alzheimer's.
To participate in this study, individuals must be diagnosed with Alzheimer's disease and be in the early or middle stages of the condition. They should be able to walk a certain distance and be receiving medication for Alzheimer's. However, those with other types of dementia, certain medical conditions that affect walking, or who have participated in exercise programs recently may not qualify. Participants can expect to be involved in treadmill exercises designed to help them improve their walking and thinking abilities, all while being supported by the research team.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Diagnosis of Alzheimer's disease according to the NINCDS-ADRDA criteria by a neurologist,
- • 2. In the early or middle stages of the disease according to the Clinical Dementia Rating Scale (CDR),
- • 3. Receiving medical treatment for Alzheimer's disease (e.g., cholinesterase inhibitors or memantine) for at least the past month,
- • 4. Able to walk at least 400 meters in the 6-Minute Walk Test, indicating functional mobility,
- • 5. Able to read and understand instructions given in Turkish.
- Exclusion Criteria:
- • 1. Having Lewy body dementia, frontotemporal dementia, or other types of dementia
- • 2. Participating in a structured exercise program within the 6 months prior to starting the study
- • 3. Having pulmonary, neurological, musculoskeletal, or rheumatological diseases that hinder walking
- • 4. Having an unstable medical condition (e.g., uncontrolled diabetes or hypertension, deep vein thrombosis, etc.)
- • 5. Having visual or auditory impairments that make communication difficult
- • 6. Having behavioral problems that make participation in exercise difficult
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported